173 related articles for article (PubMed ID: 8999432)
1. QSAR analysis of a set of benzimidazole derivatives based on their tuberculostatic activities.
Geban O; Ertepinar H; Ozden S
Pharmazie; 1996 Jan; 51(1):34-6. PubMed ID: 8999432
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues.
Gobis K; Foks H; Serocki M; Augustynowicz-Kopeć E; Napiórkowska A
Eur J Med Chem; 2015 Jan; 89():13-20. PubMed ID: 25462221
[TBL] [Abstract][Full Text] [Related]
3. Novel 2-(2-phenalkyl)-1H-benzo[d]imidazoles as antitubercular agents. Synthesis, biological evaluation and structure-activity relationship.
Gobis K; Foks H; Suchan K; Augustynowicz-Kopeć E; Napiórkowska A; Bojanowski K
Bioorg Med Chem; 2015 May; 23(9):2112-20. PubMed ID: 25797161
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of antimycobacterial activity of new benzimidazole aminoesters.
Yoon YK; Ali MA; Wei AC; Choon TS; Ismail R
Eur J Med Chem; 2015 Mar; 93():614-24. PubMed ID: 24996257
[TBL] [Abstract][Full Text] [Related]
5. In vitro tuberculostatic activities of some 2-benzylbenzimidazole and 2-phenoxymethylbenzimidazole derivatives.
Gümüs F; Altuntas TG; Saygun N; Ozden T; Ozden S
J Pharm Belg; 1989; 44(6):398-402. PubMed ID: 2517303
[TBL] [Abstract][Full Text] [Related]
6. Benzimidazole-based compounds kill Mycobacterium tuberculosis.
Gong Y; Somersan Karakaya S; Guo X; Zheng P; Gold B; Ma Y; Little D; Roberts J; Warrier T; Jiang X; Pingle M; Nathan CF; Liu G
Eur J Med Chem; 2014 Mar; 75():336-53. PubMed ID: 24556148
[TBL] [Abstract][Full Text] [Related]
7. Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis.
Gill C; Jadhav G; Shaikh M; Kale R; Ghawalkar A; Nagargoje D; Shiradkar M
Bioorg Med Chem Lett; 2008 Dec; 18(23):6244-7. PubMed ID: 18930654
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D; Peethambar SK; Achur R; Kumar HS
Eur J Med Chem; 2015 May; 95():49-63. PubMed ID: 25794789
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 3-cyclohexylpropanoic acid-derived nitrogen heterocyclic compounds and their evaluation for tuberculostatic activity.
Gobis K; Foks H; Bojanowski K; Augustynowicz-Kopeć E; Napiórkowska A
Bioorg Med Chem; 2012 Jan; 20(1):137-44. PubMed ID: 22153872
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel N' (4-aryloxybenzylidene)- 1H-benzimidazole-2 carbohydrazide derivatives as anti-tubercular agents.
Siddiki AA; Bairwa VK; Telvekar VN
Comb Chem High Throughput Screen; 2014; 17(7):630-8. PubMed ID: 24625232
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Tuberculostatic Activity Evaluation of Novel Benzazoles with Alkyl, Cycloalkyl or Pyridine Moiety.
Krause M; Foks H; Augustynowicz-Kopeć E; Napiórkowska A; Szczesio M; Gobis K
Molecules; 2018 Apr; 23(4):. PubMed ID: 29690646
[TBL] [Abstract][Full Text] [Related]
12. SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents.
Jadhav GR; Shaikh MU; Kale RP; Shiradkar MR; Gill CH
Eur J Med Chem; 2009 Jul; 44(7):2930-5. PubMed ID: 19150154
[TBL] [Abstract][Full Text] [Related]
13. Synthetic thioamide, benzimidazole, quinolone and derivatives with carboxylic acid and ester moieties: a strategy in the design of antituberculosis agents.
Ashfaq M; Shah SS; Najam T; Ahmad MM; Tabassum R; Rivera G
Curr Med Chem; 2014 Mar; 21(7):911-31. PubMed ID: 24164193
[TBL] [Abstract][Full Text] [Related]
14. A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles.
Adamec J; Waisser K; Kunes J; Kaustová J
Arch Pharm (Weinheim); 2005 Aug; 338(8):385-9. PubMed ID: 16041837
[TBL] [Abstract][Full Text] [Related]
15. Derivatives of 4(7)-methyl- and 5,6-dimethyl-benzimidazolyl-2-mercaptoacetic acids.
Czarnocka-Janowicz A; Sawlewicz J; Gilewski W; Janowiec M
Pol J Pharmacol Pharm; 1977; 29(1):69-73. PubMed ID: 404634
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles.
Shingalapur RV; Hosamani KM; Keri RS
Eur J Med Chem; 2009 Oct; 44(10):4244-8. PubMed ID: 19540630
[TBL] [Abstract][Full Text] [Related]
17. Optimized Synthesis of New Thiosemicarbazide Derivatives with Tuberculostatic Activity.
Popovici C; Pavel CM; Sunel V; Cheptea C; Dimitriu DG; Dorohoi DO; David D; Closca V; Popa M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830021
[TBL] [Abstract][Full Text] [Related]
18. Antituberculosis: synthesis and antimycobacterial activity of novel benzimidazole derivatives.
Keng Yoon Y; Ashraf Ali M; Choon TS; Ismail R; Chee Wei A; Suresh Kumar R; Osman H; Beevi F
Biomed Res Int; 2013; 2013():926309. PubMed ID: 24381946
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitubercular activity of novel amino acid derivatives.
Da Costa CF; Pinheiro AC; De Almeida MV; Lourenço MC; De Souza MV
Chem Biol Drug Des; 2012 Feb; 79(2):216-22. PubMed ID: 22078007
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, crystal studies, anti-tuberculosis and cytotoxic studies of 1-[(2E)-3-phenylprop-2-enoyl]-1H-benzimidazole derivatives.
Kalalbandi VK; Seetharamappa J; Katrahalli U; Bhat KG
Eur J Med Chem; 2014 May; 79():194-202. PubMed ID: 24735645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
